Pfizer announces positive top-line results of landmark community-acquired pneumonia immunization trial in adults evaluating efficacy of prevenar 13
Pfizer Inc. announced that the Community-Acquired Pneumonia Immunization Trial in…
24 February 2014 | By Pfizer
Pfizer Inc. announced that the Community-Acquired Pneumonia Immunization Trial in Adults achieved its primary clinical objective and both secondary clinical objectives...